María Merino

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction.

K. Cornetta, S. Rosenberg, M. Lotze, 1990, The New England journal of medicine.

Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model

P. Berraondo, I. Trocóniz, G. Kochan, 2021, Journal of Nanobiotechnology.

A new immune-nanoplatform for promoting adaptive antitumor immune response.

P. Berraondo, I. Trocóniz, S. Zalba, 2019, Nanomedicine : nanotechnology, biology, and medicine.

Correlation between anti-PD-L1 tumor concentrations and tumor-specific and nonspecific biomarkers in a melanoma mouse model

Iñaki F. Trocóniz, Ana M. Contreras, María J. Garrido, 2016, Oncotarget.

Immunoliposomes in clinical oncology: State of the art and future perspectives

S. Zalba, M. Garrido, M. Merino, 2018, Journal of controlled release : official journal of the Controlled Release Society.

EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model.

G. Koning, I. Trocóniz, C. T. de Ilarduya, 2016, Nanomedicine.

Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria

J. Lanciego, M. Alegre, F. Corrales, 2022, Science Translational Medicine.

Optimization and in-vitro/in-vivo evaluation of doxorubicin-loaded chitosan-alginate nanoparticles using a melanoma mouse model.

G. Vayssilov, P. Petkov, M. Garrido, 2019, International journal of pharmaceutics.